Genotropin Treatment In Very Young Children Born Small For Gestational Age

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

To demonstrate the effect on height and psychomotor development of Growth Hormone treatment in very young children starting at an age of 2 years.

Phase 3

Pfizer